Awardedted

SUBSTANCJA CZYNNA EMICIZUMAB wraz z sukcesywnymi dostawami do Centrów Leczenia Hemofilii

View official notice
Contracting authority
Instytut Matki i Dziecka
Estimated value
—
Submission deadline
No deadline published
Location
Polska

Notice details

Published:
1 Jan 2026
Country:
PL
CPV codes
33621000

Award

Awarded to
Roche Polska Sp. z o.o.
Award value
€279,152,782

AI analysis, documents and tracking

Create a free account to unlock the AI analysis of the tender documents, the full documentation and tracking for this tender.

Create a free account